Full Press Release Details
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology.
BIIB
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
Key Takeaway: Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology